1-20 of 56
cytogenetics
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Minimal residual disease and stem cell transplantation outcomes

Jacqueline Cloos, Gert J. Ossenkoppele, Richard Dillon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 617–625.
https://doi.org/10.1182/hematology.2019000006
Published: 2019
Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.
https://doi.org/10.1182/hematology.2019000059
Published: 2019
Journal Articles

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

Daria V. Babushok
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 457–466.
https://doi.org/10.1182/asheducation-2018.1.457
Published: 2018
Journal Articles

Fixed duration vs continuous therapy in multiple myeloma

Heinz Ludwig, Niklas Zojer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 212–222.
https://doi.org/10.1182/asheducation-2017.1.212
Published: 2017
Journal Articles

Classification and risk assessment in AML: integrating cytogenetics and molecular profiling

Matahi Moarii, Elli Papaemmanuil
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 37–44.
https://doi.org/10.1182/asheducation-2017.1.37
Published: 2017
Journal Articles

Safety profiles of novel agent therapies in CLL

Inhye E. Ahn, Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 354–357.
https://doi.org/10.1182/asheducation-2017.1.354
Published: 2017
Journal Articles

Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?

Michael Heuser
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 24–32.
https://doi.org/10.1182/asheducation-2016.1.24
Published: 2016
Journal Articles

Reclassifying myelodysplastic syndromes: what's where in the new WHO and why

Daniel A. Arber, Robert P. Hasserjian
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 294–298.
https://doi.org/10.1182/asheducation-2015.1.294
Published: 2015
Journal Articles

Molecular monitoring in CML and the prospects for treatment-free remissions

Michael W. Deininger
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 257–263.
https://doi.org/10.1182/asheducation-2015.1.257
Published: 2015
Journal Articles

Do somatic mutations in de novo MDS predict for response to treatment?

Mark A. Schroeder, Amy E. DeZern
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 317–328.
https://doi.org/10.1182/asheducation-2015.1.317
Published: 2015
Journal Articles

Intermediate-risk acute myeloid leukemia therapy: current and future

Konstanze Döhner, Peter Paschka
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 34–43.
https://doi.org/10.1182/asheducation.V2014.1.34.3882398
Published: 2014
Journal Articles

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adults

Mohamed L. Sorror, Elihu Estey
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 21–33.
https://doi.org/10.1182/asheducation-2014.1.21
Published: 2014
Journal Articles

Epigenetic targeting and personalized approaches for AML

Gail J. Roboz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 44–51.
https://doi.org/10.1182/asheducation-2014.1.44
Published: 2014
Journal Articles

Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

David T. Yeung, Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 240–243.
https://doi.org/10.1182/asheducation-2014.1.240
Published: 2014
Journal Articles

Goals for chronic myeloid leukemia TK inhibitor treatment: how little disease is too much?

Michael J. Mauro
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 234–239.
https://doi.org/10.1182/asheducation-2014.1.234
Published: 2014
Journal Articles

How should we treat newly diagnosed multiple myeloma patients?

María-Victoria Mateos, Jesús F. San Miguel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 488–495.
https://doi.org/10.1182/asheducation-2013.1.488
Published: 2013
Journal Articles

Update on current monitoring recommendations in chronic myeloid leukemia: practical points for clinical practice

Vivian G. Oehler
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 176–183.
https://doi.org/10.1182/asheducation-2013.1.176
Published: 2013
Journal Articles

Targeting signaling pathways in acute lymphoblastic leukemia: new insights

Christine J. Harrison
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 118–125.
https://doi.org/10.1182/asheducation-2013.1.118
Published: 2013
Journal Articles

Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights

Uwe Platzbecker
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 522–528.
https://doi.org/10.1182/asheducation-2013.1.522
Published: 2013
Journal Articles

High-risk acute myelogenous leukemia: treatment today … and tomorrow

Gary J. Schiller
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 201–208.
https://doi.org/10.1182/asheducation-2013.1.201
Published: 2013